Ceramat

Ceramat (now operating as Keramat) is a Spanish biotechnology company specializing in the development and manufacture of advanced bioceramics for bone regeneration. Founded as a spin-off from the University of Santiago de Compostela, the company focuses on synthetic bone graft substitutes such as hydroxyapatite and tricalcium phosphate. Its products are designed for use in dental, maxillofacial, and orthopedic surgeries to provide an osteoconductive scaffold that facilitates the repair of bone defects. Ceramat's technology emphasizes high purity and biocompatibility, offering a safe alternative to autografts and allografts. The company serves the global medical device market with a portfolio of CE-marked regenerative materials.